ACTA1 and Hepatic fibrosis: We also found that exosomes of WJ-MSCs treatment (50 μg/ml) could significantly decrease the level of TGF-β, collagen1α, and α-SMA gene expression in cholesterol-induced liver fibrosis model (Figure 3A, B, and C).